gobal chemicals trading platform prosessional chemical database look for chemicals? Go >
Current position:Home > Products >

Lunacalcipol

250384-82-8,Lunacalcipol,Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol

 

Lunacalcipol

CAS Registry Number:
250384-82-8
Synonyms:
Lunacalcipol;CTA018;250384-82-8;CTA-018;UNII-XN4TL6M50Z;Lunacalcipol [USAN];Lunacalcipol [USAN:INN];XN4TL6M50Z;CTA 018;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol;1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-;Lunacalcipol (USAN/INN);LUNACALCIPOL [INN];D00DYK;LUNACALCIPOL [WHO-DD];CHEMBL2105705;GTPL11382;CHEBI:177662;CTA018/MT2832;BDBM50023361;AKOS040752736;MT-2832;D09928;Q27293916;Lunacalcipol (intravenous, secondary hyperparathyroidism);CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma;Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma;CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma;(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol;(5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
Molecular Formula:
C28H42O4S
Molecular Weight:
474.7
EINECS:
Melting Point:
Solubility:
About us | Service | Link | Add to favorite
©2010 EaseChem.com